This episode is part of a special podcast series discussing “The Future of Health Care: Health Care Delivery and Consolidation Trends in 2020 and Beyond.” Join attorney Gary Herschman as he speaks with Darren Black, Managing...more
10/1/2020
/ Acquisitions ,
Biopharmaceutical ,
Business Strategies ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Industry Consolidation ,
Infectious Diseases ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Physicians ,
Telehealth ,
Telemedicine
This episode is part of a special podcast series discussing “The Future of Health Care: Health Care Delivery and Consolidation Trends in 2020 and Beyond.” Join attorney Gary Herschman as he speaks with Carsten Beith, Managing...more
9/24/2020
/ Acquisitions ,
Business Development ,
Business Strategies ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Industry Consolidation ,
Physicians ,
Telehealth ,
Telemedicine ,
Value-Based Care
This episode is part of a special podcast series discussing “The Future of Health Care: Health Care Delivery and Consolidation Trends in 2020 and Beyond.” Join attorney Gary Herschman as he speaks with Barry Ostrowsky,...more
9/17/2020
/ Acquisitions ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Industry Consolidation ,
Mergers ,
Personal Protective Equipment ,
Physicians ,
Public Health ,
Supply Chain ,
Telehealth ,
Telemedicine
Based on their extensive experience advising health care industry clients, Epstein Becker Green attorneys and strategic advisors from EBG Advisors are predicting the “hot” health care sectors for investment, growth, and...more
1/9/2020
/ Artificial Intelligence ,
Biologics ,
Clinical Trials ,
Electronic Medical Records ,
Health Care Providers ,
Health Information Technologies ,
Health Insurance ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Long Term Care Facilities ,
Medical Devices ,
Medicare Advantage ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Private Equity ,
Research and Development ,
Telehealth ,
Telemedicine